Amgen, Inc. (AMGN)
437.23
-6.89
(-1.55%)
USD |
NASDAQ |
Sep 04, 16:00
415.00
-22.23
(-5.08%)
After-Hours: 20:00
Amgen SG&A Expense (TTM) : 7.019B for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.019B |
| March 31, 2026 | 6.965B |
| December 31, 2025 | 7.05B |
| September 30, 2025 | 6.976B |
| June 30, 2025 | 6.881B |
| March 31, 2025 | 6.975B |
| December 31, 2024 | 7.096B |
| September 30, 2024 | 7.492B |
| June 30, 2024 | 7.22B |
| March 31, 2024 | 6.729B |
| December 31, 2023 | 6.179B |
| September 30, 2023 | 5.477B |
| June 30, 2023 | 5.411B |
| March 31, 2023 | 5.444B |
| December 31, 2022 | 5.414B |
| September 30, 2022 | 5.267B |
| June 30, 2022 | 5.285B |
| March 31, 2022 | 5.342B |
| December 31, 2021 | 5.368B |
| September 30, 2021 | 5.716B |
| June 30, 2021 | 5.757B |
| March 31, 2021 | 5.668B |
| December 31, 2020 | 5.73B |
| September 30, 2020 | 5.47B |
| June 30, 2020 | 5.347B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.312B |
| December 31, 2019 | 5.15B |
| September 30, 2019 | 5.196B |
| June 30, 2019 | 5.266B |
| March 31, 2019 | 5.359B |
| December 31, 2018 | 5.332B |
| September 30, 2018 | 5.20B |
| June 30, 2018 | 5.077B |
| March 31, 2018 | 4.933B |
| December 31, 2017 | 4.87B |
| September 30, 2017 | 4.766B |
| June 30, 2017 | 4.84B |
| March 31, 2017 | 4.923B |
| December 31, 2016 | 5.062B |
| September 30, 2016 | 5.155B |
| June 30, 2016 | 5.155B |
| March 31, 2016 | 5.023B |
| December 31, 2015 | 4.846B |
| September 30, 2015 | 4.757B |
| June 30, 2015 | 4.726B |
| March 31, 2015 | 4.702B |
| December 31, 2014 | 4.699B |
| September 30, 2014 | 4.887B |
| June 30, 2014 | 4.923B |
| March 31, 2014 | 5.043B |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 9.147B |
| Regeneron Pharmaceuticals, Inc. | 2.743B |
| AbbVie, Inc. | 14.67B |
| Biogen, Inc. | 2.594B |
| Vertex Pharmaceuticals, Inc. | 2.008B |